Product Information
DICYCLOMINE 10 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0777 per EA under NDC 00054074831. Its NADAC has been published 165 times since Aug 9, 2023.
FDA first approved this application on Feb 28, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054074831
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICYCLOMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040204FDA Approved
2/28/1997
TE Code
AB
On Market Since
2/28/1997
Pharmacological Classes
Price Statistics
The NADAC for DICYCLOMINE 10 MG CAPSULE has been published 165 times since Aug 9, 2023, and over the history we have for it it has declined 39.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0777 per EA |
|---|---|
| All-time high | $0.1282 (Aug 16, 2023) |
| All-time low | $0.0726 (Nov 20, 2024) |
| 52-week high | $0.0824 |
| 52-week low | $0.0752 |
| Median price | $0.0824 |
| Average price | $0.0895 |
| Largest weekly change | +31.5% (Aug 21, 2024) |
| Weeks tracked | 165 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dicyclomine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICYCLOMINE 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DICYCLOMINE 10 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0777 per EA (NDC 00054074831), effective Sep 30, 2026.
How has the price of DICYCLOMINE 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DICYCLOMINE 10 MG CAPSULE has declined 39.3%. It has been tracked across 165 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for DICYCLOMINE 10 MG CAPSULE?
Since Aug 9, 2023, the NADAC for DICYCLOMINE 10 MG CAPSULE has ranged from a low of $0.0726 (Nov 20, 2024) to a high of $0.1282 (Aug 16, 2023), with a median of $0.0824 per EA.
Are there cheaper alternatives to DICYCLOMINE 10 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DICYCLOMINE 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DICYCLOMINE 10 MG CAPSULE?
DICYCLOMINE 10 MG CAPSULE (NDC 00054074831) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.